| Rania Hamvas, MD | |
|
18101 Highwoods Preserve Pkwy, Tampa, FL 33647-1791 | |
| (813) 972-1030 | |
| (813) 972-2224 |
| Full Name | Rania Hamvas |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 18101 Highwoods Preserve Pkwy, Tampa, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013248996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME103355 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rania Hamvas, MD 3583 River Heights Xing Se, Marietta, GA 30067-4898 Ph: (813) 972-1030 | Rania Hamvas, MD 18101 Highwoods Preserve Pkwy, Tampa, FL 33647-1791 Ph: (813) 972-1030 |
News Archive
Results of a study presented at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif., signal a light at the end of the tunnel for individuals with inoperable locally advanced pancreatic cancer (LAPC). A new procedure called irreversible electroporation or IRE uses microsecond electrical pulses to force open and destroy tumor cells around a vast and delicate network of blood vessels of the pancreas.
Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.
Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced the relocation of its corporate headquarters to South Jordan, Utah. The new facility, located at 10653 South River Front Parkway in the recently-constructed RiverPark Corporate Center, comfortably accommodates the company's current corporate staff and operations, both of which have increased significantly in the past 18 months, and effectively facilitates additional expansion in conjunction with future growth and development.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
› Verified 5 days ago
Leslie Kapp-jones, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 E Fletcher Ave Ste 126, Tampa, FL 33613 Phone: 813-866-0930 | |
Mr. Ramon Santiago, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13250 N 56th St, Suite 101, Tampa, FL 33617 Phone: 813-988-1984 Fax: 813-988-0240 | |
Troy Michael Sterk, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3910 Northdale Blvd Ste 206, Tampa, FL 33624 Phone: 813-264-7922 Fax: 813-264-6585 | |
Mr. Jose M Garcia, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2601 N Himes Ave, Tampa, FL 33607 Phone: 813-873-8071 Fax: 813-877-4031 | |
Dr. Paul James O Braonain, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3250 Zemke Ave, Tampa, FL 33621 Phone: 813-827-9548 Fax: 203-327-2991 | |
Dr. Carl William Goodchild Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12780 Race Track Road, Suite 400, Tampa, FL 33626 Phone: 813-321-6262 Fax: 813-792-2561 |